Literature DB >> 12444837

A randomized trial of oral vs intravenous rehydration in a pediatric emergency department.

Yvonne C Atherly-John1, Sandra J Cunningham, Ellen F Crain.   

Abstract

BACKGROUND: Physicians report several barriers to the use of oral rehydration therapy (ORT) for dehydration in children due to acute gastroenteritis.
OBJECTIVES: To compare ORT with intravenous therapy for the treatment of moderate dehydration in children with acute gastroenteritis and to determine whether the factors reported as barriers to the use of ORT would be substantiated in practice.
METHODS: Randomized controlled trial in an urban pediatric emergency department. Children with moderate dehydration due to acute gastroenteritis were randomly assigned to ORT (group 1) or intravenous therapy (group 2). The primary outcome was length of stay in the emergency department. Secondary outcomes included hospital admission rate, staff time, relapse after discharge from the hospital, and parental satisfaction. Two days after discharge, parents were surveyed by telephone to assess the relapse and their satisfaction with the visit.
RESULTS: Eighteen patients were enrolled in group 1 and 16 in group 2. The mean length of stay in group 1 was 225 vs 358 minutes in group 2 (P<.01). Mean staff time was 35.8 minutes in group 1 compared with 65 minutes in group 2 (P =.03). Three patients failed ORT and required intravenous therapy. Two patients (11%) in group 1 vs 4 (25 %) in group 2 required admission to the hospital (P =.20). No patients relapsed after being discharged from the hospital. Fourteen parents (77%) in group 1 compared with 6 (37.5%) in group 2 reported that they were highly satisfied with all aspects of the visit (P =.01).
CONCLUSIONS: Reported barriers to ORT were not supported by our data. Moreover, ORT performed better than intravenous therapy on all measured outcomes.

Entities:  

Mesh:

Year:  2002        PMID: 12444837     DOI: 10.1001/archpedi.156.12.1240

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  8 in total

1.  Intravenous therapy.

Authors:  C Waitt; P Waitt; M Pirmohamed
Journal:  Postgrad Med J       Date:  2004-01       Impact factor: 2.401

2.  The impact of an oral rehydration clinical pathway in a paediatric emergency department.

Authors:  Quynh Doan; Mercedes Chan; Vicki Leung; Esther Lee; Niranjan Kissoon
Journal:  Paediatr Child Health       Date:  2010-10       Impact factor: 2.253

3.  Use of bedside ultrasound to assess degree of dehydration in children with gastroenteritis.

Authors:  Lei Chen; Allen Hsiao; Melissa Langhan; Antonio Riera; Karen A Santucci
Journal:  Acad Emerg Med       Date:  2010-10       Impact factor: 3.451

4.  The Use of a Triage-Based Protocol for Oral Rehydration in a Pediatric Emergency Department.

Authors:  Marissa A Hendrickson; Jennifer Zaremba; Andrew R Wey; Philippe R Gaillard; Anupam B Kharbanda
Journal:  Pediatr Emerg Care       Date:  2018-04       Impact factor: 1.454

5.  Treatment in the pediatric emergency department is evidence based: a retrospective analysis.

Authors:  Kellie L Waters; Natasha Wiebe; Kristie Cramer; Lisa Hartling; Terry P Klassen
Journal:  BMC Pediatr       Date:  2006-10-06       Impact factor: 2.125

6.  Understanding the use of oral rehydration therapy: A narrative review from clinical practice to main recommendations.

Authors:  Ziba Aghsaeifard; Ghobad Heidari; Reza Alizadeh
Journal:  Health Sci Rep       Date:  2022-09-11

7.  Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials.

Authors:  Steven Bellemare; Lisa Hartling; Natasha Wiebe; Kelly Russell; William R Craig; Don McConnell; Terry P Klassen
Journal:  BMC Med       Date:  2004-04-15       Impact factor: 8.775

8.  The evolving epidemiology of acute gastroenteritis in hospitalized children in Italy.

Authors:  Brigida Stanyevic; Margherita Sepich; Samanta Biondi; Giampiero Igli Baroncelli; Diego Peroni; Maria Di Cicco
Journal:  Eur J Pediatr       Date:  2021-07-29       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.